Type 2 Diabetes in Practice, second edition has been devised as a means of presenting clearcut and accessible opinion-leader advice and summary facts relevant to everyday practice.
This book confronts Type 2 Diabetes, a 'modern-age epidemic' currently estimated to affect nearly 200 million people worldwide. The complications of Type 2 Diabetes are formidable and the aetiology and pathogenesis complex. It presents major public health challenges and this book will be valuable to both primary and secondary healthcare teams.
This second edition has been extensively revised to include recent developments in this rapidly moving area of medicine.
'This is a "must buy" for the bookshelf of all health care professionals who have anything to do with diabetes. This very affordable book is beautifully presented with highlighted teaching points and a brilliant "Quick Reference Section" which contains excellent figures and algorithms. it is a clear, concise, comprehensive and contemporary practical guide to type 2 diabetes.' Practical Diabetes review of the first edition
Auflage
Sprache
Verlagsort
Zielgruppe
Editions-Typ
Illustrationen
Filled with two colour textboxes and line artworks
Maße
Höhe: 234 mm
Breite: 170 mm
ISBN-13
978-1-85315-635-9 (9781853156359)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Andrew J Krentz is a Consultant Physician at Southampton University Hospitals, UK. His clinical research interests include type 2 diabetes and the metabolic syndrome.
Clifford J Bailey is Head of Diabetes Research at Aston University, UK. Has has served as Secretary of the medical and scientific section of Diabetes UK (formerly the British Diabetic Association), held editorial positions with several journals, and is presently editor of The British Journal of Diabetes and Vascular Disease. He has acted as an expert witness to drug licensing authorities. His research involves mainly the development of new antidiabetic therapies.
1. The burden of type 2 diabetes
2. Pathophysiology
3. Classification
4. Diagnosis and assessment
5. Principles of management
6. Microvascular complications
7. Macrovascular disease
8. Non-pharmacological treatment
9. Pharmacological treatment I: aplha-glucosidase inhibitors, sulphonylureas and meglitinides
10. Pharmacological treatment II: metformin and the thiazolidinediones
11. Pharmacological treatment III: insulin
Quick reference section
Index
